The API production group has ten years experience in commercial manufacturing and production of taxane semi-synthesis. The intellectual property behind our production chemistry is well-differentiated from side-chain attachment chemistries, providing our customers with paclitaxel and docetaxel API produced on a shorter and more efficient semi-synthesis pathway. We are the only supplier of semi-synthetic taxanes independent of tree plantations.
Large Scale API Production
- 100 – 200 kg/year production capacity for API taxanes
- cGMP compliant process at Vancouver BC Canada plant
- CEP and DMF for commercial supply of Paclitaxel EP/USP
- Proprietary and non-infringing source for Docetaxel API
Patented Semi-Synthetic Chemistry
Markets
- Pharmaceuticals
- Biopharmaceuticals
- Medical Device
|
